VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years
PHASE1
Background:
* Vaccines are substances used to try to create resistance or ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...
PHASE1
Objectives:
* To evaluate the safety and tolerability of a prime-boost stu...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike